According to the report of the China Commercial Industry Research Institute, the market size of medical apparatus in China has increased from 623.50 billion yuan in 2019 to 1.0358 trillion yuan in 2023, and it is expected to reach 1.13 trillion yuan in 2024. Among them, the market for medical instruments and medical consumables will reach 415 billion yuan and 715 billion yuan respectively. As a capital, technology and talent-intensive field, the development of the medical apparatus industry urgently needs policy and financial support.
a "provincial-level specialized and innovative" little giant medical apparatus enterprise in Changsha that focuses on clinical mass spectrometry has successfully developed a number of leading products, realized a closed-loop system for clinical application of chromatography mass spectrometry, and mastered the underlying technology and core component manufacturing process. However, due to the scarcity of upstream parts and high R & D expenses, enterprises are facing financial pressure.
Changsha Branch of Industrial Bank of China quickly established an agile service team after learning about the needs of the enterprise, came to understand the situation and communicated product solutions. Considering that the enterprise has completed equity financing, the bank decided to use "investment and loan linkage loan" for loan business report and triple the credit amount. The company completed the withdrawal in the same month, highly recognizing the professional and efficient services of Industrial Bank.
In order to implement the strategic transformation of science and technology finance, Industrial Bank Changsha Branch has deeply cultivated early and medium-term technology enterprises in the region, and has issued loans of more than 90 million yuan to nearly 30 enterprises.
